Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71205-286

3 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71205-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)

Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)
Chemical structure of Zolpidem Tartrate, showing the molecular arrangement of the active ingredient zolpidem and the tartrate moiety.*
FDA Label Image

Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)

Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)
A line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) following administration of 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate-release tablets. The graph shows concentration curves for both formulations up to 8 hours post-dose.*
FDA Label Image

71205-286-30 (B0207b5f 53fa 4b2c 8608 4095874aff98 04)

71205-286-30 (B0207b5f 53fa 4b2c 8608 4095874aff98 04)
Zolpidem Tartrate 12.5 mg extended-release tablets label from Proficient Rx LP. The film-coated tablets are blue, biconvex, round, debossed with 'E62' on one side and 'LU' on the other. The label includes NDC 71205-286-30 and indicates prescription-only status with a Schedule C-IV classification. Pack contains 30 tablets, stored at 25°C, manufactured by Lupin Limited in Goa, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.